TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ZYME

Zymeworks Inc.

Healthcare · Biotechnology

27.50$ +4.7% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Zymeworks Inc. (ZYME)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.8% of the shares are freely tradable; institutional investors hold 98.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 98.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 92.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 10.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 71Mio.

Largest Shareholders

Institutions

Institutions ZYME
Name Stake (%) Shares Change (%) Date
EcoR1 Capital, LLC 32.12 22,970,388 +0.0 06/30/2026
Rubric Capital Management LP 9.79 7,000,000 +21.7 03/31/2026
BlackRock Inc 6.37 4,553,888 -0.9 03/31/2026
Perceptive Advisors LLC 5.85 4,182,953 +19.2 06/30/2026
Bvf Inc 5.22 3,734,142 -5.2 03/31/2026
Morgan Stanley - Brokerage Accounts 3.47 2,480,568 -4.3 03/31/2026
BNP Paribas Investment Partners SA 2.67 1,908,039 +4.7 03/31/2026
Vanguard Capital Management, LLC 2.39 1,705,580 +0.0 03/31/2026

Funds

Funds ZYME
Name Stake (%) Shares Change (%) Date
HBM Healthcare Investments AG Ord 3.53 2,522,736 +0.0 06/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.11 1,508,613 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?